QualityStocksNewsBreaks – OS Therapies Inc. (NYSE American: OSTX) Heads to Moody Capital Conference Amid Major OST-HER2 Regulatory Push
OS Therapies (NYSE American: OSTX) announced its upcoming participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9-10 in New York City, where OS Animal Health will participate and the company is expected to engage with investors and strategic partners. The conference comes as OS Therapies enters a potentially significant regulatory period for OST-HER2, its investigational therapy for fully resected pulmonary metastatic osteosarcoma. The company expects interim three-year overall survival data and key FDA and U.K. regulatory meetings in September, followed by potential RMAT and Rolling Review decisions, with final three-year data, a U.S.…
